SV Health Investors

SV Health Investors

A venture capital firm in Massachusetts that focuses on biotechnology and healthcare industry.

SV Health Investors is a venture capital firm in Massachusetts that focuses on biotechnology and healthcare industry. Founded 1993 in Boston, Massachusetts, United States, it invests in debt, early stage ventures, late stage ventures, series B, series A, and series D rounds. Its portfolio companies include Xilio Therapeutics, EBT Medical, Ervaxx, Healthify, Clarify Medical, Bardy Diagnostics, CSA Medical, Rheostat Therapeutics, Ribometrix, and Urgent Team Holdings, Inc. As of April 2020, SV Health Investors has made 216 investments. Their most recent investment was on March 2, 2020, when Xilio Therapeutics raised $100.5M. V Health Investors has had 38 exits, the most notable of which include Bicycle Therapeutics, Avrobio, and Sutro Biopharma. The company has raised seven funds, their latest being SV7 Growth Fund.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Healthify

Healthify is a company founded by Manik Bhat, Eric Allen Conner, Daniel Levenson and Alex Villa.

A company focused on devloping human monoclonal and bispecific antibodies for oncology, immunomodulation, inflammation, neuroscience and pain

Evidation Health is a health and measurement company providing technical support to biopharmaceutical and healthcare companies.

Developing gene therapies to potentially cure rare diseases.

A company developing hemodynamic monitoring solutions to detect heart failure

A biopharmaceutiical company discovering, developing and manufacturing therapeutics for the treatment of canccer

Pionyr Immunotherapeutics is a San Francisco-based biotechnology company and developer of cancer immunotherapies designed to target the tumor microenvironment.

A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases

Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells

A pharmaceutical company that develops topical eye drops for the treatment of eye diseases

A company developing cancer therapeutics

A pharmaceutical company focused to develop anti-infective medicines

A biopharmaceutical company developing therapeutics for skin disorders

A company that develops cell therapies to treat kidney diseases

A company developing cancer therapeutics

CardioKinetix is a Menlo Park, California-based company.

Clarify Medical is a San Diego-based company.

Panoptica is a company founded by Evgeniy Grahev.

Cibiem is a Los Altos, California-based company.

24 Results
Results per page:
Page 1 of 1

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
SV7 Growth Fund, L.P.
250,000,000
September 2019
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

David Milne

Managing Partner

Jacqueline Grant

Senior Associate

Michael Balmuth

Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

EBT Medical

Ervaxx

Healthify

Xilio Therapeutics

News

Title
Author
Date
Publisher
Description
Amirah Al Idrus
November 23, 2020
FierceBiotech
Cell therapies have seen success in some blood cancers, but the same can't be said for solid tumors. Several biotechs have sprung up to close that gap in different ways, but Catamaran Bio thinks single "linchpin" approaches won't be enough. Instead, it's taking a multipronged approach shepherded by a team of cell therapy and biopharma veterans.
FinSMEs
November 23, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Mattha Busby
November 8, 2020
the Guardian
Kate Bingham speaking on television in September. Photograph: ITV/Rex/Shutterstock
Mattha Busby
November 8, 2020
the Guardian
Report claims Kate Bingham's venture capital firm has invested in companies developing Covid-19 antibody cocktails

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.